News|Podcasts|January 9, 2024
Prioritizing R&D Initiatives to Support Cell Line Development
Author(s)AGC Biologics
Robust, scalable manufacturing of novel therapeutics requires partnering with a CDMO equipped to adapt to changes in the market and knowledgeable on the latest technologies used to support cell line development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
3
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
4
Why Radiopharmaceuticals Are Ideal for Treating Cancer
5
